Edition:
United States

Kyorin Holdings Inc (4569.T)

4569.T on Tokyo Stock Exchange

2,210JPY
8:35pm EDT
Change (% chg)

¥-14 (-0.63%)
Prev Close
¥2,224
Open
¥2,213
Day's High
¥2,224
Day's Low
¥2,210
Volume
25,600
Avg. Vol
190,556
52-wk High
¥2,700
52-wk Low
¥2,155

Chart for

About

KYORIN Holdings, Inc. is a Japan-based holding company mainly engaged in the manufacture and sale of pharmaceuticals. The Company operates in two business segments. The Pharmaceuticals segment is engaged in the manufacture, purchase and sale of pharmaceutical products, the evaluation of technologies, the inspection, analysis and... (more)

Overall

Beta: 0.82
Market Cap(Mil.): ¥167,058.30
Shares Outstanding(Mil.): 74.95
Dividend: 20.00
Yield (%): 2.60

Financials

  Industry Sector
P/E (TTM): -- 31.87 16.33
EPS (TTM): -- -- --
ROI: -- 15.11 14.66
ROE: -- 16.37 13.99

BRIEF- Kyorin Holdings unit Kyorin Pharmaceutical to buy jTAS

* Says its unit Kyorin Pharmaceutical Co Ltd will acquire 100 percent stake in jTAS Inc

Jun 23 2017

BRIEF-Kyorin Holdings to integrate production function

* Says it plans to set up new production subsidiary to take over business from Noshiro plant of unit Kyorin Pharmaceutical Company, Limited and manufacture division of KYORIN Rimedio Co.,Ltd.

May 11 2017

BRIEF-Kyorin holdings likely will see 10 percent rise in group operating profit for year ending in March 2018 - Nikkei

* Kyorin Holdings likely will see a 10 percent rise in group operating profit for the year ending in March 2018 - Nikkei

Apr 17 2017

BRIEF-KYORIN Holdings unit gets license from Merck for drug KRP-114V

* Says its pharma unit receives license from US firm Merck & Co Inc for drug KRP-114V, a treatment for overactive bladder, owning exclusive rights to develop and commercialize in Asian area

Apr 11 2017

Earnings vs. Estimates